Linnea Thorlacius

16PUBLICATIONS
38CO-AUTHORS
Major global burdens of diseaseAllergyEpidemiological modellingDisease surveillanceHuman biophysics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 22, 2026
HiSQOL-mini: Development and Validation of a Shortened Version of the Hidradenitis Suppurativa Quality of Life (HiSQOL) Instrument.

|Jun 05, 2026
Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II.

|Jul 13, 2025
Bimekizumab Impact on Patient-Reported Outcomes in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II.

Vivian Y Shi, John R Ingram, Hadar Lev-Tov

|Apr 02, 2025
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.

Joslyn S Kirby, Linnea Thorlacius, Jérémy Lambert

|Nov 17, 2023
Global consensus process to establish a core dataset for hidradenitis suppurativa registries.

Hannah E Wainman, Nisha S Chandran, John W Frew

|Mar 27, 2021
How to diagnose and measure primary hyperhidrosis: a systematic review of the literature.

Mattias A S Henning, Linnea Thorlacius, Kristina S Ibler

Pageof 3

Frequent Collaborators

9 joint publications

John R Ingram

6 joint publications

Amit Garg

6 joint publications

Gregor B Jemec

5 joint publications

Peter Theut Riis